APOE and metabolic syndrome: In a cohort study involving patients with metabolic syndrome (MetSyn), diagnosed based on the presence of at least three or more components from the list of central obesity, reduced HDL-cholesterol, elevated plasma triglycerides or glucose, or high blood pressure, ApoE glycosylation in VLDL, LDL, and HDL fractions was observed to be decreased by 17, 30, and 25%, respectively.